Tamiya, H.; Nishino, K.; Kato, Y.; Nakahashi-Kato, R.; Kosuga-Tsujimoto, Y.; Kinoshita, S.; Suzuki, R.; Watanabe, M.; Wakamatsu, T.; Kakunaga, S.;
et al. Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types. Curr. Oncol. 2025, 32, 42.
https://doi.org/10.3390/curroncol32010042
AMA Style
Tamiya H, Nishino K, Kato Y, Nakahashi-Kato R, Kosuga-Tsujimoto Y, Kinoshita S, Suzuki R, Watanabe M, Wakamatsu T, Kakunaga S,
et al. Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types. Current Oncology. 2025; 32(1):42.
https://doi.org/10.3390/curroncol32010042
Chicago/Turabian Style
Tamiya, Hironari, Kazumi Nishino, Yuji Kato, Reina Nakahashi-Kato, Yurika Kosuga-Tsujimoto, Shota Kinoshita, Rie Suzuki, Makiyo Watanabe, Toru Wakamatsu, Shigeki Kakunaga,
and et al. 2025. "Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types" Current Oncology 32, no. 1: 42.
https://doi.org/10.3390/curroncol32010042
APA Style
Tamiya, H., Nishino, K., Kato, Y., Nakahashi-Kato, R., Kosuga-Tsujimoto, Y., Kinoshita, S., Suzuki, R., Watanabe, M., Wakamatsu, T., Kakunaga, S., & Takenaka, S.
(2025). Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types. Current Oncology, 32(1), 42.
https://doi.org/10.3390/curroncol32010042
